Risk factors associated with clinically relevant pericardial effusion after primary cardiac implantable electronic device implantation

被引:0
作者
Zhou, Yangzhi [1 ]
Haxha, Saranda [1 ,2 ]
Halili, Andrim [1 ,2 ]
Philbert, Berit T. [3 ]
Nielsen, Olav W. [1 ]
Sajadieh, Ahmad [1 ]
Koeber, Lars [3 ]
Gislason, Gunnar H. [4 ]
Torp-Pedersen, Christian
Bang, Casper N. [1 ]
机构
[1] Bispebjerg & Frederiksberg Hosp, Dept Cardiol, Copenhagen, Denmark
[2] North Zealand Hosp, Dept Cardiol, Hillerod, Denmark
[3] Copenhagen Univ Hosp, Rigshosp, Dept Cardiol, Copenhagen, Denmark
[4] Herlev Gentofte Hosp, Dept Cardiol, Copenhagen, Denmark
关键词
cardiac implantable electronic device; cardiac tamponade; clinically relevant pericardial effusion; pericardiocentesis; postprocedural complication; ANTIPLATELET THERAPY; PACEMAKER; COMPLICATIONS; PERFORATION; PREDICTORS; ANTICOAGULATION; AMYLOIDOSIS; MANAGEMENT; HEPARIN;
D O I
10.1111/jce.16442
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Pericardial effusion, a known complication to implantation of cardiac implantable electronic devices (CIED), may cause life-threatening cardiac tamponade. Limited knowledge is available about risk factors for clinically relevant procedural pericardial effusion. The aim is to identify the patient- and procedure-related risk factors associated with clinically relevant procedural pericardial effusion. Method: A nationwide observational cohort study based on data on 55 121 patients from the Danish Pacemaker Register between 2000 and 2018. We defined a clinically relevant procedural pericardial effusion related to the implantation if it occurred within 90 days after the primary CIED-procedure. Prespecified risk factors were analysed by multivariable logistic regression models to estimate the association with pericardial effusion. Results: There were 115 (0.21%) patients diagnosed with clinically relevant procedural pericardial effusion, with a median age of 75 years and 38.3% were females. Of these, 80.9% lead to a subsequent pericardiocentesis procedure. In adjusted logistic regression analysis, an increased risk of clinically relevant pericardial effusion was associated with female sex (OR:1.49 [95%CI: 1.03-2.16]), heart failure (OR:1.54 [95%CI: 1.06-2.23]), previous cardiac surgery (OR:1.63 [95%CI: 1.05-2.55]), CRT-device (OR:2.05 [95%CI: 1.23-3.41]), tertiary-centres (OR:1.8 [95%CI: 1.18-2.73]), increased procedural volume per year (>1000) (OR:1.85 [95%CI: 1.03-3.30]), indication of device-implantation (atrioventricular block) (OR:2.37 [95CI: 1.45-3.87]), and increasing number of leads implanted (two leads (OR:2.39 [95%CI: 1.43-4.00]), three leads (OR:4.77 [95%CI: 2.50-9.10])). Conclusion: Clinically relevant procedural pericardial effusion is a rare complication after CIED-implantation in Denmark. This study reveals important patient- and procedure-related risk factors associated with clinically relevant procedural pericardial effusion.
引用
收藏
页码:2314 / 2328
页数:16
相关论文
共 38 条
  • [1] The management of cardiac implantable electronic device lead perforations: a multicentre study
    Acha, Moshe Rav
    Rafael, Allon
    Keaney, John J.
    Elitzur, Yair
    Danon, Asaf
    Shauer, Ayelet
    Taha, Louay
    Shechter, Yonat
    Bogot, Naama R.
    Luria, David
    Ilan, Michael
    Singh, Sheldon M.
    Mela, Theofanie
    Weisz, Giora
    Glikson, Michael
    Medina, Aharon
    [J]. EUROPACE, 2019, 21 (06): : 937 - 943
  • [2] Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation
    Ahmed, Imdad
    Gertner, Elie
    Nelson, William B.
    House, Chad M.
    Dahiya, Ranjan
    Anderson, Christopher P.
    Benditt, David G.
    Zhu, Dennis W. X.
    [J]. HEART RHYTHM, 2010, 7 (06) : 745 - 749
  • [3] Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation
    Birnie, David H.
    Healey, Jeff S.
    Wells, George A.
    Verma, Atul
    Tang, Anthony S.
    Krahn, Andrew D.
    Simpson, Christopher S.
    Ayala-Paredes, Felix
    Coutu, Benoit
    Leiria, Tiago L. L.
    Essebag, Vidal
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (22) : 2084 - 2093
  • [4] Cardiac tamponade in catheter ablation of atrial fibrillation: German-wide analysis of 21 141 procedures in the Helios atrial fibrillation ablation registry (SAFER)
    Bollmann, Andreas
    Ueberham, Laura
    Schuler, Ekkehard
    Wiedemann, Michael
    Reithmann, Christopher
    Sause, Armin
    Tebbenjohanns, Juergen
    Schade, Anja
    Shin, Dong-In
    Staudt, Alexander
    Zacharzowsky, Udo
    Ulbrich, Michael
    Wetzel, Ulrike
    Neuser, Hans
    Bode, Kerstin
    Kuhlen, Ralf
    Hindricks, Gerhard
    [J]. EUROPACE, 2018, 20 (12): : 1944 - 1951
  • [5] Brock J., 2020, Danish Pacemaker and ICD Register Annual Report 2020 Danish Pacemaker and ICD RegisterAnnual Report 2020 2 Preface
  • [6] EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin-American Heart Rhythm Society (LAHRS)
    Burri, Haran
    Starck, Christoph
    Auricchio, Angelo
    Biffi, Mauro
    Burri, Mafalda
    D'Avila, Andre
    Deharo, Jean-Claude
    Glikson, Michael
    Israel, Carsten
    Lau, Chu-Pak
    Leclercq, Christophe
    Love, Charles J.
    Nielsen, Jens Cosedis
    Vernooy, Kevin
    Dagres, Nikolaos
    Boveda, Serge
    Butter, Christian
    Marijon, Eloi
    Braunschweig, Frieder
    Mairesse, Georges H.
    Gleva, Marye
    Defaye, Pascal
    Zanon, Francesco
    Lopez-Cabanillas, Nestor
    Guerra, Jose M.
    Vassilikos, Vassilios P.
    Oliveira, Mario Martins
    [J]. EUROPACE, 2021, 23 (07): : 983 - +
  • [7] Incidence and predictors of clinically relevant cardiac perforation associated with systematic implantation of active-fixation pacing and defibrillation leads: a single-centre experience with over 3800 implanted leads
    Cano, Oscar
    Andres, Ana
    Alonso, Pau
    Osca, Joaquin
    Sancho-Tello, Maria-Jose
    Olague, Jose
    Martinez-Dolz, Luis
    [J]. EUROPACE, 2017, 19 (01): : 96 - 102
  • [8] Dual-Chamber Implantable Cardioverter-Defibrillator Selection Is Associated With Increased Complication Rates and Mortality Among Patients Enrolled in the NCDR Implantable Cardioverter-Defibrillator Registry
    Dewland, Thomas A.
    Pellegrini, Cara N.
    Wang, Yongfei
    Marcus, Gregory M.
    Keung, Edmund
    Varosy, Paul D.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (10) : 1007 - 1013
  • [9] Effect of Direct Oral Anticoagulants, Warfarin, and Antiplatelet Agents on Risk of Device Pocket Hematoma Combined Analysis of BRUISE CONTROL 1 and 2
    Essebag, Vidal
    Healey, Jeff S.
    Joza, Jacqueline
    Nery, Pablo B.
    Kalfon, Eli
    Leiria, Tiago L. L.
    Verma, Atul
    Ayala-Paredes, Felix
    Coutu, Benoit
    Sumner, Glen L.
    Becker, Giuliano
    Philippon, Francois
    Eikelboom, John
    Sandhu, Roopinder K.
    Sapp, John
    Leather, Richard
    Yung, Derek
    Thibault, Bernard
    Simpson, Christopher S.
    Ahmad, Kamran
    Toal, Satish
    Sturmer, Marcio
    Kavanagh, Katherine
    Crystal, Eugene
    Wells, George A.
    Krahn, Andrew D.
    Birnie, David H.
    [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2019, 12 (10)
  • [10] Pericardial Disease in Cancer Patients
    Ghosh A.K.
    Crake T.
    Manisty C.
    Westwood M.
    [J]. Current Treatment Options in Cardiovascular Medicine, 2018, 20 (7)